General Information
Version
7.07
Revision date
2024-06-19
Product name
Cleanser/Thinner No.13
CAS No.
78-93-3
1.2.1 Relevant identified uses
Paint or paint related material
1.2.2. Uses advised against
Industrial use only
Icons in SDS
Company Information
company name
Sherwin-Williams UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
hse.pm.emea@sherwin.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319, H336
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mono-constituent substance
Signal word
Danger
Hazard statements
Highly flammable liquid and vapour. Causes serious eye irritation. May cause drowsiness or dizziness.
Prevention
Wear eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Avoid breathing vapour.
Response
IF INHALED: Call a POISON CENTER or doctor if you feel unwell. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
Not applicable.
Hazardous Ingredients
Methyl Ethyl Ketone
Supplemental label elements
Repeated exposure may cause skin dryness or cracking. FOR INDUSTRIAL USE ONLY
Special packaging requirements
Not applicable.
2.3 Other hazards
Product meets the criteria PBT P B T vPvB vP vB
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mono-constituent substance Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Flam. Liq. 2, H225 Eye Irrit. 2, H319 STOT SE 3, H336 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. C13 SECTION 2: Hazards identification See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
